Relax your tight end? What a Super Bowl ad got right about prostate cancer screening [CNN]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: CNN
If you watched the Super Bowl, you probably saw commercials featuring NFL players telling America to “ relax your tight end .” The campaign from drugmaker Novartis — called “Relax, It's a Blood Test” — featured tight ends Rob Gronkowski and George Kittle and Super Bowl-winning coach Bruce Arians, who's a prostate cancer survivor. Amid the other ads, it did something we struggle to do in medicine: Get men to pay attention to prostate cancer screening. The real message was targeting men's fear. A lot of men avoid prostate cancer screening because they assume it automatically means a rectal exam. Relax, all these tough football players said — for many men, screening starts with a simple blood test and a conversation. What does ‘relax your tight end' actually mean? It means stop letting fear of the exam keep you from getting checked out for a treatable cancer. The first step for many men is a PSA test, a blood test that measures prostate-specific antigen. A digital rectal exa
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU) [Yahoo! Finance]Yahoo! Finance
- Novartis (NYSE:NVS) had its "hold" rating reaffirmed by analysts at TD Cowen.MarketBeat
- Should Vanrafia Kidney Data and Dividend Move Reshape the Novartis (SWX:NOVN) Autoimmune Investment Case? [Yahoo! Finance]Yahoo! Finance
- Is It Too Late To Consider Novartis (SWX:NOVN) After Strong Multi-Year Share Gains? [Yahoo! Finance]Yahoo! Finance
- Novartis (NYSE:NVS) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.MarketBeat
NVS
Earnings
- 2/4/26 - Beat
NVS
Sec Filings
- 2/12/26 - Form 144
- 2/9/26 - Form 144
- 2/4/26 - Form S-8
- NVS's page on the SEC website